Law360, New York (August 05, 2010, 7:18 PM ET) -- A federal appeals court on Thursday breathed new life into Adams Respiratory Therapeutics Inc.'s suit accusing Perrigo Co. of infringing a patent in its attempt to introduce its own version of the expectorant Mucinex.
The U.S. Court of Appeals for the Federal Circuit vacated a February ruling granting the generic-drug manufacturer summary judgment, finding that a lower court had made mistakes with its claims construction.
Adams Respiratory, a unit of Reckitt Benckiser Group PLC, sued Perrigo in 2007, alleging that Perrigo's proposal to manufacture a generic...
Fed. Circ. Vacates Perrigo Win In Mucinex ANDA Spat
To view the full article, take a free trial now.
